Adma Biologics (ADMA) Free Cash Flow (QoQ) (2011 - 2025)
Adma Biologics (ADMA) Free Cash Flow (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Adma Biologics | 2.02 Bn | 1.93 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,314.42% |
| Sep 30, 2025 | -105.74% |
| Jun 30, 2025 | 176.78% |
| Mar 31, 2025 | -151.36% |
| Dec 31, 2024 | 97.98% |
| Sep 30, 2024 | -44.99% |
| Jun 30, 2024 | 1,054.65% |
| Mar 31, 2024 | -127.84% |
| Dec 31, 2023 | 46.06% |
| Sep 30, 2023 | 262.00% |
| Jun 30, 2023 | 58.42% |
| Mar 31, 2023 | -49.79% |
| Dec 31, 2022 | 33.23% |
| Sep 30, 2022 | 0.63% |
| Jun 30, 2022 | 41.88% |
| Mar 31, 2022 | 22.31% |
| Dec 31, 2021 | -129.25% |
| Sep 30, 2021 | 55.90% |
| Jun 30, 2021 | -2.62% |
| Mar 31, 2021 | 0.05% |